Market Trends of Vitamin D Therapy Industry
Oral Route of Administration is Expected to Hold the Major Share in the Market Over the Forecast Period
Oral administration of vitamin D is a common practice in treating vitamin D deficiency. The oral route of administration is expected to account for the largest share over the forecast period. This is owing to the ease of administration, safety, efficiency, reduced chances of toxicity coupled with patient compliance, and preference for the oral route due to availability in various forms like chewing gums and tablets, driving the market. In addition, the increasing awareness of vitamin D deficiency due to the high burden, increasing research activities for vitamin D deficiency conditions like osteoporosis and rickets, and the growing elderly population are expected to drive the market over the forecast period.
For instance, as per the report published by BMC Public Health in October 2021, the prevalence of vitamin D deficiency in Europe, the United States, and the Middle East has been reported to range from 20% to 90%. This shows the widespread disease throughout the world with a significant burden on people. Hence, with a high burden of vitamin D deficiency, the demand for treatment increases, which is expected to boost the market over the study period.
Furthermore, in April 2021, the Oireachtas Health Committee launched a report to address Vitamin D deficiency in Ireland. The Committee received information demonstrating widespread vitamin D deficiency in the community, and the report urges the establishment of public health initiatives to treat this deficiency. These public health interventions are advised to lower the risk of respiratory and other ailments, such as osteoporosis. One of the recommendations is to take oral Vitamin D supplementation of 20-25µg/day for the adult population as a public health measure. Hence, with new recommendations, the market is expected to grow over the forecast period through this segment.
North America is Expected to have Significant Share in the Market Over the Forecast Period
North America is expected to have a significant share in the overall vitamin D therapy market throughout the forecast period. This is mainly owing to the presence of leading players based in the United States, focusing on research activities to develop more patient-compliant products with enhanced efficiency coupled with government support and increasing healthcare expenditure, contributing to its outstanding market revenue share in the vitamin D therapy market growth.
Decreased physical activity (PA), obesity, and low social status are also associated with low vitamin D levels. For instance, the CDC report published in January 2022 stated that 25% of American adults are not physically active enough to maintain their health. Physical inactivity rates at the state and territory level range from 17.7% of individuals in Colorado to 49.4% in Puerto Rico. Hence, decreasing physical activity among the people in the region leads to an increased risk of vitamin D deficiency and is likely to raise the demand for treatment and drive the market to grow.
Furthermore, the new product approvals and launches help the market to grow through the widespread of the products in the region. For instance, in November 2022, in Canada, Genestra Brands released two new extra-strength vitamin D supplements, D-Mulsion 2500 and D3 2500. With just one capsule or drop daily, the new extra-strength formula is for those with an increased risk of vitamin D deficiency. Hence, the new approvals and launches of products create new applications and increase the demand, which is expected to drive the market to grow through this region.
